TORADOL

This brand name is authorized in Brazil, Canada, Finland, Hong Kong SAR China, Italy, South Africa, Spain, UK.

Active ingredients

The drug TORADOL contains one active pharmaceutical ingredient (API):

1	Ketorolac tromethamine UNII 4EVE5946BQ - KETOROLAC TROMETHAMINE
	Ketorolac is a non-steroidal anti-inflammatory agent demonstrating analgesic and anti-inflammatory activity. Ketorolac inhibits the cyclo-oxygenase enzyme essential for biosynthesis of prostaglandins. Ketorolac has been shown to reduce prostaglandin levels in the aqueous humour after topical ophthalmic administration.
	Read more about Ketorolac

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M01AB15	Ketorolac	M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AB Acetic acid derivatives and related substances
Discover more medicines within M01AB15

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	509017020014207
CA	Health Products and Food Branch	02162644, 02162660
ES	Centro de información online de medicamentos de la AEMPS	58976
FI	Lääkealan turvallisuus- ja kehittämiskeskus	582250
GB	Medicines & Healthcare Products Regulatory Agency	40616
HK	Department of Health Drug Office	35309
IT	Agenzia del Farmaco	027253020
ZA	Health Products Regulatory Authority	28/2.7/0570, 28/2.7/0571, 28/2.7/0572